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Introduction: Consistent and efficient use of any analytical procedure requires the knowledge of its reliability prior to its use. It is therefore necessary for each laboratory to validate their analytical methods. Validation is not only required by regulatory authorities [ICH, FDA, GxP] or in order to obtain accreditation [ISO 17025, ISO 15189], but is also the ultimate phase before the routine use of the method. Analytical method validation must bring confidence to the laboratories in the results that will be generated since they are used to make critical decisions. However, very little information is included about the process and rules for making a decision – i.e. to reject or to accept an analytical method - with respect to its ability to achieve reliable results.
Aim: An innovative universal strategy using Total Error is thus proposed to decide about the method’s validity that controls the risk of accepting an unsuitable assay together with the ability to predict the reliability of future results. Several examples of applications of this validation methodology to various types of assays [LC-MS, ELISA, Bio-Assays] will be presented.
Method: Total Error is the simultaneous combination of systematic (bias) and random (imprecision) error of analytical methods. Using validation standards both types of error are combined through the use of a prediction interval (β-expectation tolerance interval). Finally, an accuracy profile is built by connecting, on one hand all the upper tolerance limits, and on the other hand all the lower tolerance limits. This profile combined with pre-specified acceptance limits (e.g. 30% for bioanalysis) allows to evaluate the validity of any quantitative analytical method.
Results: The accuracy profile determines a region of results where a defined proportion of future measurements will be included inside the acceptance limits. If the analyst is willing to take, for example, a risk of 5%, this approach can give the laboratory as well as the regulatory authorities the guarantee that 95 times out of 100 the future measurements of unknown samples using the validated method will be included within the acceptance limits assessed according to the requirements. The accuracy profile is used to select the most appropriate standard curve, to estimate the limit(s) of quantification, to evaluate a potential matrix effect and, nonetheless provide estimates of measurement uncertainty.
Conclusions: This validation methodology approach allows the analysts as well as the regulatory bodies to know the risk of obtaining future results out of the specified acceptance limit. Validation criteria such as the selection of the adequate standard curve and definition of the lower and upper limits of quantitation are straightforward and fit perfectly to their respective definition. Using the proposed approach, each analyst can predict the quality of the results that he will provide and thus earn confidence in the subsequent critical decisions made.
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